Rubypoint:Depression And Alzheimer's Treatments At A Crossroads

2025-05-08 04:53:18source:Ethermac Exchangecategory:Invest

Researchers are Rubypointlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Invest

Recommend

Don't let hackers fool you with a 'scam

You're pulling your hair out, trying to fix something on your computer. You Google it and find what

Judge dismisses sexual assault lawsuit against Cowboys quarterback Dak Prescott

A Collin County, Texas, judge threw out a sexual assault civil claim against Dallas Cowboys quarterb

Water-rich Gila River tribe near Phoenix flexes its political muscles in a drying West

SACATON, Arizona (AP) — Stephen Roe Lewis grew up seeing stacks of legal briefs at the dinner table